[{"id":"156d54c5-8d8f-476f-89e1-cf5c28672101","acronym":"","url":"https://clinicaltrials.gov/study/NCT05098327","created_at":"2021-10-28T17:56:21.946Z","updated_at":"2024-07-02T16:35:39.988Z","phase":"Phase 3","brief_title":"Pioglitazone and Insulin Resistance in ADT","source_id_and_acronym":"NCT05098327","lead_sponsor":"State University of New York at Buffalo","biomarkers":" AKT2 • IRS1 • TLR4 • MAPK8 • SOCS3","pipe":"","alterations":" ","tags":["AKT2 • IRS1 • TLR4 • MAPK8 • SOCS3"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2021","start_date":" 08/01/2021","primary_txt":" Primary completion: 03/31/2023","primary_completion_date":" 03/31/2023","study_txt":" Completion: 03/31/2023","study_completion_date":" 03/31/2023","last_update_posted":"2023-08-15"},{"id":"ca630f27-b6f4-4e41-8b6a-f0ab6deef1e5","acronym":"","url":"https://clinicaltrials.gov/study/NCT02010021","created_at":"2021-01-18T09:10:44.994Z","updated_at":"2024-07-02T16:37:03.738Z","phase":"","brief_title":"Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.","source_id_and_acronym":"NCT02010021","lead_sponsor":"Dartmouth-Hitchcock Medical Center","biomarkers":" HER-2 • ER • IRS1","pipe":" | ","alterations":" ER positive • HER-2 negative","tags":["HER-2 • ER • IRS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e letrozole"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 01/01/2014","start_date":" 01/01/2014","primary_txt":" Primary completion: 12/08/2017","primary_completion_date":" 12/08/2017","study_txt":" Completion: 12/08/2017","study_completion_date":" 12/08/2017","last_update_posted":"2019-01-17"}]